Brian Culley

Lineage Cell Therapeutics' CEO, Brian Culley, discusses overcoming challenges during pandemic, regulatory progress, collaborations with Roche and Genentech, advancements in AMD and spinal cord treatments, organizational transformation, upcoming programs in eye and hearing, cost-effective cell therapy development, and future potentials beyond oncology.